113 related articles for article (PubMed ID: 7284260)
1. Pharmaceutical formulations of anthralin.
Whitefield M
Br J Dermatol; 1981 Aug; 105 Suppl 20():28-32. PubMed ID: 7284260
[No Abstract] [Full Text] [Related]
2. The interaction of anthralin, salicylic acid and zinc oxide in pastes.
Hulsebosch HJ; Ponec-Waelsch M
Dermatologica; 1972; 144(5):287-93. PubMed ID: 4663601
[No Abstract] [Full Text] [Related]
3. Further studies on the interaction between anthralin salicylic acid and zinc oxide in pastes.
Ponec-Waelsch M; Hulsebosch HJ
Arch Dermatol Forsch; 1974; 249(2):141-52. PubMed ID: 4420796
[No Abstract] [Full Text] [Related]
4. [Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne].
Orfanos CE; Steigleder GK
Z Hautkr; 1976 Jun; 51(12):473-80. PubMed ID: 952029
[No Abstract] [Full Text] [Related]
5. Factors affecting the clearance of psoriasis with dithranol (anthralin).
Comaish S; Smith J; Seville RH
Br J Dermatol; 1971 Mar; 84(3):282-9. PubMed ID: 5572679
[No Abstract] [Full Text] [Related]
6. [Treatment of psoriasis with salicylic acid, tar and dithranol].
Juhlin L
Lakartidningen; 1979 Oct; 76(43):3758-9. PubMed ID: 529922
[No Abstract] [Full Text] [Related]
7. [A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
Steigleder GK; Schulze HJ
Z Hautkr; 1984 Feb; 59(3):188, 191-2. PubMed ID: 6719977
[TBL] [Abstract][Full Text] [Related]
8. The treatment of chronic psoriasis a two-centre comparative study.
Khan SA; Williamson DM; Gatecliff M; Tosh J
Practitioner; 1981 Jun; 225(1356):932-4. PubMed ID: 7029508
[No Abstract] [Full Text] [Related]
9. Anthralin therapy for psoriasis.
Statham BN; Ryatt KS; Rowell NR
J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
[No Abstract] [Full Text] [Related]
10. Advances in the use of anthralin.
Seville RH
J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the mode of action of anthralin in the treatment of psoriasis.
Br J Dermatol; 1981 Aug; 105 Suppl 20():1-114. PubMed ID: 7284252
[No Abstract] [Full Text] [Related]
12. Anthralin therapy for psoriasis. A new look at an old compound.
Gorsulowsky DC; Voorhees JJ; Ellis CN
Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
[No Abstract] [Full Text] [Related]
13. [Antipsoriatic effect of dithranol (anthralin). 2].
Raab W
Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
[No Abstract] [Full Text] [Related]
14. [Antipsoriatic effect of dithranol (anthralin). 1].
Raab W
Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
[TBL] [Abstract][Full Text] [Related]
15. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
Kunze J; Petres J
Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
[TBL] [Abstract][Full Text] [Related]
16. Treatment of psoriasis with the Ingram anthralin paste regimen.
Ross JB; Guptill J
Can Med Assoc J; 1982 Mar; 126(5):496. PubMed ID: 7066806
[No Abstract] [Full Text] [Related]
17. The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
Portnoy B; Beck MH
Acta Derm Venereol; 1981; 61(5):459-61. PubMed ID: 6172945
[No Abstract] [Full Text] [Related]
18. Anthralin inhibition of intraepidermal pustule formation.
Stone OJ
Int J Dermatol; 1986 Mar; 25(2):136. PubMed ID: 3699956
[No Abstract] [Full Text] [Related]
19. Dithranol-UV-A phototherapy (DUVA) for psoriasis: a treatment without dressings.
Hindson C; Diffey B; Lawlor F; Downey A
Br J Dermatol; 1983 Apr; 108(4):457-60. PubMed ID: 6838770
[TBL] [Abstract][Full Text] [Related]
20. Innovative use of anthralin. An overview of past, present and future developments.
Farber EM; Nall L
Br J Dermatol; 1981 Aug; 105 Suppl 20():111-4. PubMed ID: 7284256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
